Qiangen Wu
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 7
- Cannabis and Cannabinoid Research 6
- Drug-Induced Hepatotoxicity and Protection 5
-
- Air Quality and Health Impacts 6
- Indoor Air Quality and Microbial Exposure 5
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 8
- Chemical Health and Safety top 10%
-
- HIV/AIDS drug development and treatment 4
-
- Diet, Metabolism, and Disease 4
- Co-authors
- Matthew BryantLei GuoJia‐Long FangXuefei CaoBaitang NingLevan MuskhelishviliNan MeiKelly J. Davis
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Qiangen Wu
45 papers receiving 821 citations
Peers
Comparison fields: 5 of 120
- Pharmacology 139
- Health, Toxicology and Mutagenesis 180
- Cancer Research 163
- Chemical Health and Safety 6
- Hepatology 40
Countries citing papers authored by Qiangen Wu
This map shows the geographic impact of Qiangen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangen Wu more than expected).
Fields of papers citing papers by Qiangen Wu
This network shows the impact of papers produced by Qiangen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangen Wu. The network helps show where Qiangen Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiangen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 23 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 14 | |
| 11 | 2018 | 33 | |
| 12 | 2018 | 8 | |
| 13 | 2018 | 12 | |
| 14 | 2018 | 23 | |
| 15 | 2018 | 33 | |
| 16 | 2017 | 14 | |
| 17 | 2016 | 39 | |
| 18 | 2016 | 74 | |
| 19 | 2013 | 7 | |
| 20 | 2010 | 16 |
About Qiangen Wu
Qiangen Wu is a scholar working on Chemical Health and Safety, Pharmacology and Health, Toxicology and Mutagenesis, having authored 49 papers that have together received 834 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Air Quality and Health Impacts (6 papers), Cannabis and Cannabinoid Research (6 papers), Indoor Air Quality and Microbial Exposure (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), HIV/AIDS drug development and treatment (4 papers) and Diet, Metabolism, and Disease (4 papers). The work is most often cited by research in Pharmacology (139 citations), Health, Toxicology and Mutagenesis (180 citations) and Cancer Research (163 citations). Qiangen Wu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Matthew Bryant, Lei Guo, Jia‐Long Fang, Xuefei Cao, Baitang Ning, Levan Muskhelishvili, Nan Mei, Kelly J. Davis, Frederick A. Beland and Lisa M. Kamendulis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.